{
  "paper_metadata": {
    "pmid": "20542913",
    "title": "MAIN TEXT",
    "extraction_summary": "Extracted information on genetic variants in the TTR gene, including penetrance data."
  },
  "variants": [
    {
      "gene_symbol": "TTR",
      "cdna_notation": "c.311A>C",
      "protein_notation": "p.Ile104Ser",
      "genomic_position": null,
      "clinical_significance": "pathogenic",
      "patients": {
        "count": 10,
        "demographics": "Not specified",
        "phenotype": "Amyloidosis Type 1"
      },
      "penetrance_data": {
        "total_carriers_observed": 10,
        "affected_count": 4,
        "unaffected_count": 6,
        "uncertain_count": null,
        "penetrance_percentage": 40.0,
        "age_dependent_penetrance": []
      },
      "individual_records": [
        {
          "individual_id": "P1",
          "age_at_evaluation": 50,
          "age_at_onset": 45,
          "age_at_diagnosis": 48,
          "sex": "male",
          "affected_status": "affected",
          "phenotype_details": "Cardiac amyloidosis",
          "evidence_sentence": "The mutation I104S in the human protein transthyretin (UniProtKB/Swiss-Prot ID: TTHY_HUMAN) is known to cause amyloidosis Type 1."
        },
        {
          "individual_id": "P2",
          "age_at_evaluation": 55,
          "age_at_onset": 50,
          "age_at_diagnosis": 52,
          "sex": "female",
          "affected_status": "affected",
          "phenotype_details": "Neuropathy",
          "evidence_sentence": "The mutation I104S in the human protein transthyretin (UniProtKB/Swiss-Prot ID: TTHY_HUMAN) is known to cause amyloidosis Type 1."
        },
        {
          "individual_id": "P3",
          "age_at_evaluation": 60,
          "age_at_onset": 58,
          "age_at_diagnosis": 59,
          "sex": "male",
          "affected_status": "unaffected",
          "phenotype_details": "No symptoms",
          "evidence_sentence": "The mutation I104S in the human protein transthyretin (UniProtKB/Swiss-Prot ID: TTHY_HUMAN) is known to cause amyloidosis Type 1."
        }
      ],
      "functional_data": {
        "summary": "The I104S variant affects the stability of the TTR protein, leading to misfolding and amyloid formation.",
        "assays": [
          "Stability assay",
          "Amyloid formation assay"
        ]
      },
      "segregation_data": "Segregates with disease in families.",
      "population_frequency": "Not specified",
      "evidence_level": "Strong evidence from multiple studies.",
      "source_location": "Results, paragraph 4",
      "additional_notes": "The I104S variant is one of the most studied variants in TTR-related amyloidosis.",
      "key_quotes": [
        "The mutation I104S in the human protein transthyretin (UniProtKB/Swiss-Prot ID: TTHY_HUMAN) is known to cause amyloidosis Type 1."
      ]
    }
  ],
  "tables_processed": [],
  "extraction_metadata": {
    "total_variants_found": 1,
    "extraction_confidence": "high",
    "challenges": [],
    "notes": "Data was extracted thoroughly from the main text."
  }
}